Circulating Tumor DNA Using Tagged Targeted Deep Sequencing to Assess Minimal Residual Disease in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy

In breast cancer patients undergoing neoadjuvant chemotherapy before surgery, there is an unmet need for noninvasive predictive biomarkers of response. The analysis of circulating tumor DNA (ctDNA) in particular has been the object of several reports, but few of them have studied the applicability o...

Descripción completa

Detalles Bibliográficos
Autores principales: Cirmena, Gabriella, Garuti, Anna, De Mariano, Marilena, Coco, Simona, Ferrando, Lorenzo, Isnaldi, Edoardo, Barbero, Valentina, Fregatti, Piero, Del Mastro, Lucia, Ferrando, Fabio, Gonella, Roberta, Garlaschi, Alessandro, Friedman, Daniele, Ballestrero, Alberto, Zoppoli, Gabriele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196957/
https://www.ncbi.nlm.nih.gov/pubmed/32377196
http://dx.doi.org/10.1155/2020/8132507

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196957/
https://www.ncbi.nlm.nih.gov/pubmed/32377196
http://dx.doi.org/10.1155/2020/8132507

Ejemplares similares